Last year, Pfizer’s CEO announced that once the government ended its public health emergency for the pandemic, the company planned to quadruple the price it charged Americans for its COVID-19 vaccine. The new price, $130, was a 10,000% markup over what analysts believe is Pfizer’s manufacturing cost.
At the price it charged the government, $30, Pfizer had still made a killing. In its first full year of sales, Pfizer had $36.7 billion in worldwide vaccine revenue, representing a stunning 45% of all its sales. It was the biggest selling drug in pharma history in its debut. Last year, Pfizer pulled in another $32 billion.
Moderna added $19 billion last year for its mRNA vaccine. Not bad for a company that had never managed to successfully get a single drug to the market before its Covid vaccine. Little wonder that Moderna followed Pfizer’s lead in setting its upcoming vaccine prices at $130. Evidently no one is aware, or cares, that price fixing is still illegal.
The U.S. government g…
